A61B5/42

SYSTEMS AND METHODS FOR ANALYSIS OF URINE AND FECAL MATTER

A miniaturized monitoring device can include electronic circuitry, housing, and communications protocols. The device can be a robust sensing device that can quantify electrolyte content accurately and transmit continuously from within fecal effluent or urine, or other human bodily fluid and/or solid samples. The device can be fully immersed in the testing sample, which can be in a container, an ostomy bag, or otherwise.

Sampling capsule system and methods
10980482 · 2021-04-20 ·

A non-invasive system for sampling gastrointestinal microbiota with their associated environment for discovery, characterization, medical research, diagnostics, and treatment using an ingestible, non-digestible sampling capsule. The capsule device, with ports open for acquiring a sample of gastrointestinal microbiota and content, is placed inside an immediate or delayed release capsule. When the outer capsule dissolves according to its specifications, enteric fluid and content enters the sampling capsule through the ports triggering a hydrophilic stop to release a pulling force to close the ports by enveloping the capsule outer casing over the inner casing, capturing the sample, and holding it sealed until it completes passage through the digestive track, and is recovered from feces for analysis.

SCANNER SYSTEM FOR DETECTING BODY CONDITION FROM VARIOUS BODY READINGS: TEMPERATURE, SIGNALS, WAVEFORM AND BIO-PHYSIOLOGICAL CHANGES
20210137465 · 2021-05-13 ·

Data analysis is combined with physiological data to provide indications of the health of bodily systems both acute and chronic time frames. The results can confirm the uniqueness of bio-metric security. It can also enhance both sport safety, rehab and fitness goals. The compared change(s) pattern can help for remote/self health monitor as well as wellness tracking.

SYSTEMS APPROACH TO DISEASE STATE AND HEALTH ASSESSMENT
20210043325 · 2021-02-11 · ·

Methods, systems, and apparatus for assessing a state of an epilepsy disease or a comorbidity thereof are provided. The methods comprise receiving at least one autonomic index, neurologic index, stress marker index, psychiatric index, endocrine index, adverse effect of therapy index, physical fitness index, or quality of life index of a patient; comparing the at least one index to at least one reference value; and assessing a state of an epilepsy disease or a body system of the patient based on the comparison. A computer readable program storage device encoded with instructions that, when executed by a computer, perform the method described above is also provided. A medical device system capable of implementing the method described above is also provided.

Nearly isotropic dipole antenna system

Systems and methods described herein can use near field communications to locate a radiating transmitter, such as a pill transmitter swallowed by a patient. In some embodiments, the pill transmitter can include multiple transmitting elements configured to transmit signals in an axis orthogonal with respect to each other. Further, in some embodiment, the pill transmitter can also include multiple transmitting elements in each of the three axes where the three axes may be perpendicular with respect to each other. The magnetic field emitted from the pill transmitter can be measured by the receiving antennas, for example, using principles of mutual inductance.

REMOTE ASSESSMENT OF NEUROSTIMULATION
20210077017 · 2021-03-18 ·

The present disclosure relates to a system (1) for remote assessment of a patient (P1), comprising: a first device (2) associated to a physician (P2), a second device (3) associated to the patient (P1), a medical device (4) associated to the patient (P1), wherein the second device (3) is configured to communicate with the medical device (4), and wherein the medical device (4) is configured to be programmed via the second device (3), wherein the first device (2) is further configured to communicate with the second device (3), and wherein the second device (3) is configured to be controlled via the first device (2), and wherein the second device (3) is configured to acquire data (S1, S2) indicative of at least one physiological parameter or of several physiological parameters (HR, F, P) of the patient (P1). Furthermore, a method for remote assessment is provided.

INTESTINAL ATTACHMENT DEVICE
20210060318 · 2021-03-04 ·

An intestinal attachment device is provided that includes an ingestible housing with a chamber having disposed therein a low-profile ribbon with a head that serves as a single attachment area for an anchor sized and configured to attach to the mucosal surface of an intestine. A disposable material is also disposed within the chamber and at least partially surrounds the ribbon. An anchor is disposed within the housing and is attached to the head of the low-profile ribbon. The anchor has a constrained and a non-constrained state and is sized and configured to attach to the mucosal surface of the intestine. The anchor is at least partially surrounded by a dissolvable material.

Non-cerebral organ autoregulation status determination
10932673 · 2021-03-02 · ·

A system for monitoring autoregulation may include processing circuitry configured to receive a blood pressure signal indicative of an acquisition blood pressure of a patient at an acquisition site and an oxygen saturation signal indicative of an oxygen saturation of the patient. The processing circuitry may determine a cerebral autoregulation status value based on the blood pressure signal and the oxygen saturation signal. The processing circuitry may determine a non-cerebral autoregulation status value based on the cerebral autoregulation status value and an adjustment value. The processing circuitry provide to an output device a signal indicative of the non-cerebral autoregulation status value and a signal indicative of the cerebral autoregulation status value to enable a clinician to monitor the autoregulation status of the patient.

ANIMAL HEALTH ASSESSMENT
20210035289 · 2021-02-04 ·

The present teachings generally include techniques for characterizing the health of an animal (e.g., gastrointestinal health) using image analysis (e.g., of a stool sample) as a complement, alternative, or a replacement to biological specimen sequencing. The present teachings may also or instead include techniques for personalizing a health and wellness plan (including, but not limited to, a dietary supplement such as a customized formula based on a health assessment), where such a health and wellness plan may be based on one or more of the health characterization techniques described herein. The present teachings may also or instead include techniques or plans for continuous care for an animal, e.g., by executing health characterization and heath planning techniques in a cyclical fashion. A personalized supplement system (e.g., using a personalized supplement, personalized dosing device, and personalized packaging) may also or instead be created using the present teachings.

AUTOMATIC TREATMENT OF PAIN
20210023300 · 2021-01-28 ·

Disclosed are methods and medical device systems for automated delivery of therapies for pain and determination of need for and safety of treatment. In one embodiment, such a medical device system may comprise a sensor configured to sense at least one body signal from a patient; and a medical device configured to receive a first sensed body signal from the sensor; determine a patient pain index based at least in part on said first sensed body signal; determine whether said patient pain index is above at least a first pain index threshold; determine a safety index based at least in part on a second sensed body signal; select a pain treatment regimen based on at least one of said safety index and or a determination that said pain index is above said first pain index threshold; and deliver said pain treatment regimen.